Provigil and Nexium: Conflicting Conclusions About Accelerated Entry Provisions in Hatch-Waxman Settlements

  • Mark Ford, Peter Spaeth
  • 12.5.2014

2014-12-5-bloomberg-bna-provigill-and-nexlum-conflicting-conlusions

Not sure where to start?

Let our Knowledge Navigator direct you to content specific to where you are on your journey.

Get Started!
Featured
blog-launch-550x370

This blog post explores certain specific terms in term sheets that will create legally binding obligations.

Schall launch feature

Partner Gary Schall shares some practical advice about term sheets: Don’t attempt any transaction without one.

Rss Feed
2.22.2025
We need to talk about the F word (‘friction’ in enterprise, that is) 
2.22.2025
The rise of browser-use agents: Why Convergence’s Proxy is beating OpenAI’s Operator 
2.22.2025
Meta launches $50M Meta Horizon Creator Fund 
Build
Document Generator  
Startup Dictionary  
2.20.2025
Corporate Transparency Act: Judge Clears Way for CTA; Reporting Requirements Back in Effect
2.12.2025
Corporate Transparency Act: It’s Still Paused (For Now)
12.27.2024
Corporate Transparency Act: Preliminary Injunctive Relief Reinstated by Fifth Circuit (For Now)